Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapy

被引：2
作者：
Meyer, Ralph M. [1 ,2 ,3 ,4 ]
Hoppe, Richard T. [5 ]
机构：
[1] Queens Univ, NCIC, Clin Trials Grp, Kingston, ON, Canada
[2] Queens Univ, Dept Oncol, Kingston, ON, Canada
[3] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada
[4] Queens Univ, Dept Commun Hlth & Epidemiol, Kingston, ON K7L 3N6, Canada
[5] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA
来源：
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM | 2012年
关键词：
INVOLVED-FIELD RADIOTHERAPY; COMBINED-MODALITY TREATMENT; COMBINATION CHEMOTHERAPY; PRACTICE GUIDELINES; MOPP CHEMOTHERAPY; NODE RADIOTHERAPY; CLINICAL-TRIALS; DISEASE; VINBLASTINE; ABVD;
D O I：
10.1182/asheducation-2012.1.313
中图分类号：
G40 [教育学];
学科分类号：
040101 ; 120403 ;
摘要：
The results of recent clinical trials for the management of limited-stage Hodgkin lymphoma have led to considerable debate, especially regarding the role of radiation therapy. This review highlights those recent trials and provides perspectives regarding their interpretation from a radiation oncologist and a hematologist. The trial protocol is available at http://www.nejm.org/doi/suppl/10.1056/NEJMoa1111961/suppl_file/nejmoa1111961_protocol.pdf.
引用
收藏
页码：313 / 321
页数：9
相关论文
共 50 条
  • [21] Early-Stage Favorable Hodgkin's Lymphoma: Is Chemotherapy Alone Sufficient?
    Ozsahin, Mahmut
    Ozsahin, Hulya
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (32) : E668 - E669
  • [22] Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma
    Engert, Andreas
    Pluetschow, Annette
    Eich, Hans Theodor
    Lohri, Andreas
    Doerken, Bernd
    Borchmann, Peter
    Berger, Bernhard
    Greil, Richard
    Willborn, Kay C.
    Wilhelm, Martin
    Debus, Juergen
    Eble, Michael J.
    Soekler, Martin
    Ho, Antony
    Rank, Andreas
    Ganser, Arnold
    Truemper, Lorenz
    Bokemeyer, Carsten
    Kirchner, Hartmut
    Schubert, Joerg
    Kral, Zdenek
    Fuchs, Michael
    Mueller-Hermelink, Hans-Konrad
    Mueller, Rolf-Peter
    Diehl, Volker
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (07) : 640 - 652
  • [23] Radiation therapy for early stage unfavorable Hodgkin lymphoma: is dose reduction feasible?
    Laskar, Siddhartha
    Kumar, Deepak P.
    Khanna, Nehal
    Menon, Hari
    Sengar, Manju
    Arora, Brijesh
    Gujral, Sumeet
    Shet, Tanuja
    Sridhar, Epari
    Rangarajan, Venkatesh
    Muckaden, Mary Ann
    Nair, Reena
    Banavali, Shripad
    LEUKEMIA & LYMPHOMA, 2014, 55 (10) : 2356 - 2361
  • [24] COMPARISON OF FAVORABLE EARLY-STAGE HODGKIN'S LYMPHOMA TREATMENTS: A SINGLE-INSTITUTION REVIEW
    Samant, Rajiv
    Alomary, Ibraheem
    Alsaeed, Eyad
    Al-jasir, Badr
    Bence-Bruckler, Isabelle
    Cross, Peter
    Genest, Paul
    Huebsch, Lothar
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (04): : 1166 - 1170
  • [25] Treatment of Favorable, Limited-Stage Hodgkin's Lymphoma With Chemotherapy Without Consolidation by Radiation Therapy
    Canellos, George P.
    Abramson, Jeremy S.
    Fisher, David C.
    LaCasce, Ann S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (09) : 1611 - 1615
  • [26] The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease
    Evens, Andrew M.
    Kostakoglu, Lale
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2014, : 135 - 143
  • [27] Controversies in the treatment of early and intermediate stage Hodgkin's lymphoma
    Sasse, S.
    Behringer, K.
    Semrau, R.
    Engert, A.
    ONKOLOGE, 2014, 20 (05): : 448 - +
  • [28] The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease
    Evens, Andrew M.
    Kostakoglu, Lale
    BLOOD, 2014, 124 (23) : 3356 - 3364
  • [29] Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin's lymphoma
    Gotti, Manuel
    Nicola, Marta
    Lucioni, Marco
    Fiaccadori, Valeria
    Ferretti, Virginia
    Sciarra, Roberta
    Costanza, Mariangela
    Bono, Elisa
    Molo, Silvana
    Maffi, Aldo
    Croci, Giorgio A.
    Varettoni, Marzia
    Frigeni, Marco
    Pascutto, Cristiana
    Arcaini, Luca
    Bonfichi, Maurizio
    Paulli, Marco
    Cazzola, Mario
    HEMATOLOGICAL ONCOLOGY, 2017, 35 (03) : 296 - 302
  • [30] Treatment for Early-Stage Hodgkin Lymphoma: Has Radiotherapy Had Its Day?
    Radford, John
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (31) : 3783 - 3785
12345